Innovative Product Portfolio Vivasure Medical specializes in fully absorbable, patch-based vessel closure devices, including their flagship PerQseal Elite system and developing PerQseal Blue, which offers sutureless, bioresorbable solutions for large-bore vascular procedures—highlighting significant opportunities for sales in hospitals and cardiovascular centers seeking advanced minimally invasive devices.

Recent Regulatory Milestones The company achieved European CE mark approval for the PerQseal Elite system in April 2025 and is pursuing US and EU regulatory clearances for its devices, presenting an accessible entry point into European and North American markets, ideal for sales efforts targeting high-growth regions demanding regulatory-compliant innovations.

Strategic Investment Backing With over $32 million in funding and major investments from Haemonetics, Vivasure is well-capitalized with strong backing for expansion into new markets and advancing product development, offering opportunities to engage with key decision-makers interested in innovative, globally-scaled medical devices.

Growth in Vascular Closure Market As a company focused on large-bore, minimally invasive vascular closure technology in a growing segment, Vivasure’s emphasis on absorbable solutions aligns with market trends toward reducing post-procedure complications and improving patient outcomes, making it an attractive partner for clinical adoption and hospital procurement.

Expanding Global Footprint Based in Galway's leading MedTech cluster with international VC support, Vivasure is positioned for international expansion, especially into US and European markets, creating opportunities for sales teams to target hospitals, outpatient clinics, and cardiovascular specialists adopting new closure technologies.